HALO
Halozyme Therapeutics Inc
$78.12
1.09 (1.41%) Today
0.15 (0.20%) After-hours
— up— down
Market Cap
$9.15B+50.5%
Revenue (TTM)
$1.46B+39.1%
Net Income (TTM)
$329.77M-26.2%
EPS (TTM)
2.78-26.2%
Shares Out
118.61M
118.61MP/E Ratio
26.32
26.32Forward P/E
7.78
7.78Open
$77.46
$77.46Previous Close
$77.18
$77.18Day Range
$77.19 – $78.94
$77.19 – $78.9452-Week Range
$51.78 – $82.22
$51.78 – $82.22Beta
0.85
0.85Volume
1.65M
1.65MAvg Volume
1.69M
1.69MAnalyst Rating
Buy
BuyExchange
NASDAQ NMS - GLOBAL MARKET
NASDAQ NMS - GLOBAL MARKETAbout HALO
Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment.
